Mandate

Vinge advises Stendörren in connection with issuance of green capital securities and tender offer

May 17, 2024 Banking and Finance

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green subordinated and perpetual capital securities in an amount of SEK 300 million (within a framework of SEK 400 million) and its parallel tender offer in respect of its previously issued capital securities.

The capital securities were issued with a coupon of STIBOR 3m + 550 basis points until the first ordinary call date, and they are intended to be listed on the sustainable bond list of Nasdaq Stockholm. An amount equivalent to the net proceeds from the issuance will be applied in accordance with Stendörren’s green finance framework and towards the repurchase of its outstanding capital securities. Stendörren has received tenders in a total nominal amount of SEK 132,500,000 and intends to accept all tenders received.

Skandinaviska Enskilda Banken AB (publ) and Swedbank AB (publ) acted as arrangers and joint bookrunners in connection with the issuance of the green capital securities, and as dealer managers in connection with the tender offer.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda and Calle Tengwall Pagels.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025